
Binu Thomas
Examiner (ID: 12732, Phone: (571)270-7684 , Office: P/1717 )
| Most Active Art Unit | 1717 |
| Art Unit(s) | 1717 |
| Total Applications | 891 |
| Issued Applications | 585 |
| Pending Applications | 109 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6327825
[patent_doc_number] => 20100197701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'METHOD OF TREATING DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/755931
[patent_app_country] => US
[patent_app_date] => 2010-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19020
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197701.pdf
[firstpage_image] =>[orig_patent_app_number] => 12755931
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/755931 | Method of treating diabetes | Apr 6, 2010 | Issued |
Array
(
[id] => 6321172
[patent_doc_number] => 20100196522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'COMPOSITIONS CONTAINING AMINES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/754716
[patent_app_country] => US
[patent_app_date] => 2010-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9234
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196522.pdf
[firstpage_image] =>[orig_patent_app_number] => 12754716
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/754716 | Compositions containing amines and use thereof | Apr 5, 2010 | Issued |
Array
(
[id] => 6276170
[patent_doc_number] => 20100256187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'COMPOSITION OF 2,4,6- TRIFLUORO-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE'
[patent_app_type] => utility
[patent_app_number] => 12/753489
[patent_app_country] => US
[patent_app_date] => 2010-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15948
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256187.pdf
[firstpage_image] =>[orig_patent_app_number] => 12753489
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/753489 | COMPOSITION OF 2,4,6- TRIFLUORO-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE | Apr 1, 2010 | Abandoned |
Array
(
[id] => 6276441
[patent_doc_number] => 20100256229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'COMPOSITIONS OF CHOLINESTERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/753567
[patent_app_country] => US
[patent_app_date] => 2010-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 16946
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256229.pdf
[firstpage_image] =>[orig_patent_app_number] => 12753567
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/753567 | COMPOSITIONS OF CHOLINESTERASE INHIBITORS | Apr 1, 2010 | Abandoned |
Array
(
[id] => 6276212
[patent_doc_number] => 20100256194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/750957
[patent_app_country] => US
[patent_app_date] => 2010-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9043
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256194.pdf
[firstpage_image] =>[orig_patent_app_number] => 12750957
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/750957 | PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THE SAME | Mar 30, 2010 | Abandoned |
Array
(
[id] => 6644382
[patent_doc_number] => 20100227841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'Patient populations and treatment methods'
[patent_app_type] => utility
[patent_app_number] => 12/732164
[patent_app_country] => US
[patent_app_date] => 2010-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22755
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20100227841.pdf
[firstpage_image] =>[orig_patent_app_number] => 12732164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/732164 | Patient populations and treatment methods | Mar 24, 2010 | Abandoned |
Array
(
[id] => 6546628
[patent_doc_number] => 20100222315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Patient populations and treatment methods'
[patent_app_type] => utility
[patent_app_number] => 12/731692
[patent_app_country] => US
[patent_app_date] => 2010-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22462
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222315.pdf
[firstpage_image] =>[orig_patent_app_number] => 12731692
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/731692 | Patient populations and treatment methods | Mar 24, 2010 | Abandoned |
Array
(
[id] => 5978258
[patent_doc_number] => 20110071199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'Thiophenyl Sulfonamides for the Treatment of Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 12/724949
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13880
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071199.pdf
[firstpage_image] =>[orig_patent_app_number] => 12724949
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/724949 | Thiophenyl Sulfonamides for the Treatment of Alzheimer's Disease | Mar 15, 2010 | Abandoned |
Array
(
[id] => 9831973
[patent_doc_number] => 08940789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'Neurite elongation agent, memory-improving agent and anti-Alzheimer agent comprising 4′-demethylnobiletin or 4′-demethyltangeretin as active ingredient, and process for production of the compound'
[patent_app_type] => utility
[patent_app_number] => 13/321988
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 7715
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321988
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/321988 | Neurite elongation agent, memory-improving agent and anti-Alzheimer agent comprising 4′-demethylnobiletin or 4′-demethyltangeretin as active ingredient, and process for production of the compound | Mar 9, 2010 | Issued |
Array
(
[id] => 7657326
[patent_doc_number] => 20110306595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'SPIROPYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/201570
[patent_app_country] => US
[patent_app_date] => 2010-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23961
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306595.pdf
[firstpage_image] =>[orig_patent_app_number] => 13201570
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201570 | Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease | Feb 19, 2010 | Issued |
Array
(
[id] => 8690023
[patent_doc_number] => 08389551
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'Optical enantiomers of phenyramidol and process for chiral synthesis'
[patent_app_type] => utility
[patent_app_number] => 12/706171
[patent_app_country] => US
[patent_app_date] => 2010-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 10562
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12706171
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/706171 | Optical enantiomers of phenyramidol and process for chiral synthesis | Feb 15, 2010 | Issued |
Array
(
[id] => 7778642
[patent_doc_number] => 20120041036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'SUBSTITUTED ACYLGUANIDINE DERIVATIVES (AS AMENDED)'
[patent_app_type] => utility
[patent_app_number] => 13/148448
[patent_app_country] => US
[patent_app_date] => 2010-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9060
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041036.pdf
[firstpage_image] =>[orig_patent_app_number] => 13148448
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148448 | SUBSTITUTED ACYLGUANIDINE DERIVATIVES (AS AMENDED) | Feb 7, 2010 | Abandoned |
Array
(
[id] => 6249327
[patent_doc_number] => 20100137365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Long chain N-alkyl compounds and oxa-derivatives thereof'
[patent_app_type] => utility
[patent_app_number] => 12/656370
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12654
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137365.pdf
[firstpage_image] =>[orig_patent_app_number] => 12656370
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/656370 | Long chain N-alkyl compounds and oxa-derivatives thereof | Jan 27, 2010 | Abandoned |
Array
(
[id] => 7561765
[patent_doc_number] => 20110275598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'COSMETIC USE OF PROANTHOCYANIDIN A2'
[patent_app_type] => utility
[patent_app_number] => 13/142661
[patent_app_country] => US
[patent_app_date] => 2010-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2307
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275598.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142661
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142661 | COSMETIC USE OF PROANTHOCYANIDIN A2 | Jan 26, 2010 | Abandoned |
Array
(
[id] => 9273645
[patent_doc_number] => 08637577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-28
[patent_title] => 'Desensitizing drug product'
[patent_app_type] => utility
[patent_app_number] => 13/145743
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5036
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145743
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145743 | Desensitizing drug product | Jan 21, 2010 | Issued |
Array
(
[id] => 6402111
[patent_doc_number] => 20100179209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'Pactimibe medicaments for preventing/treating a disease due to sebaceous gland dysfunction in humans or animals'
[patent_app_type] => utility
[patent_app_number] => 12/688310
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2236
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20100179209.pdf
[firstpage_image] =>[orig_patent_app_number] => 12688310
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/688310 | Pactimibe medicaments for preventing/treating a disease due to sebaceous gland dysfunction in humans or animals | Jan 14, 2010 | Abandoned |
Array
(
[id] => 7733549
[patent_doc_number] => 20120015945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'USE OF CB1 ANTAGONISTS AND/OR INVERSE AGONISTS FOR THE PREPARATION OF DRUGS THAT INCREASE MOTOR NEURON EXCITABILITY'
[patent_app_type] => utility
[patent_app_number] => 13/144078
[patent_app_country] => US
[patent_app_date] => 2010-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8146
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015945.pdf
[firstpage_image] =>[orig_patent_app_number] => 13144078
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/144078 | Use of CB1 antagonists and/or inverse agonists for the preparation of drugs that increase motor neuron excitability | Jan 10, 2010 | Issued |
Array
(
[id] => 6320112
[patent_doc_number] => 20100196285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Use of Deuterium Oxide to Treat Virus-Based Diseases of the Respiratory Tract'
[patent_app_type] => utility
[patent_app_number] => 12/652939
[patent_app_country] => US
[patent_app_date] => 2010-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21554
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196285.pdf
[firstpage_image] =>[orig_patent_app_number] => 12652939
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/652939 | Use of Deuterium Oxide to Treat Virus-Based Diseases of the Respiratory Tract | Jan 5, 2010 | Abandoned |
Array
(
[id] => 7574171
[patent_doc_number] => 20110269827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'USE OF LIPOIC ACID FOR TREATING OR PREVENTING DEGENERATIVE JOINT CONDITIONS, OSTEOARTHRITIS, CARTILAGE DAMAGE, AND RELATED DISORDERS IN COMPANION ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 13/142913
[patent_app_country] => US
[patent_app_date] => 2009-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8908
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269827.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142913
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142913 | Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals | Dec 28, 2009 | Issued |
Array
(
[id] => 8968655
[patent_doc_number] => 08507466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-13
[patent_title] => 'Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy'
[patent_app_type] => utility
[patent_app_number] => 12/655240
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 27
[patent_no_of_words] => 22558
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12655240
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/655240 | Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy | Dec 22, 2009 | Issued |